Please login to the form below

Not currently logged in
Email:
Password:

Shire experiences sales growth thanks to ADHD drug

Shire reported a rise in sales and revenues on the back of the success of new drugs such as the much-criticised medicine, Vyvanse, on February 21.

Shire reported a rise in sales and revenues on the back of the success of new drugs such as the much-criticised medicine, Vyvanse, on February 21.

Investors' concerns over the attention deficit and hyperactivity disorder (ADHD) treatment were alleviated as Shire reported a 41 per cent increase in sales at the end of 2007.

Total company revenues were up by 36 per cent of which 23 per cent was thanks to the sale of new medications.

Matthew Emmens, chief executive officer of Shire, said: "The launch of Vyvanse continues to progress well and we are confident about the medication's future growth supported by new clinical studies."

US-based researchers reported last year that ADHD drugs could stunt growth and did not improve behaviour over a sustained period of time [PMLive November 2007].

Emmens said: ëThe acquisition of New River Pharmaceuticals (April 2007) gave us full ownership and control of Vyvanse and this new generation ADHD treatment is establishing itself in the US, where it has already gained a market share of 6 per cent.î

22nd February 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
CSafe Global

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

Latest intelligence

Big data, privacy and the rise of genomic testing
Blue Latitude Health speaks to Johan Christiaanse, Marketing Director at BGI, to find out how the medical profession can overcome one of the major barriers to precision medicine – big...
Deal Watch January 2018
...
Emotional Intelligence and Blended Learning in Healthcare
EI and emotional selling are rising up the agenda when it comes to healthcare training. This article outlines how blended learning approaches can help put them into action....

Infographics